Advertisements


Retailers sue Allergan over dry-eye drug

Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease......»»

Category: topSource: moneycentralMay 16th, 2018

Ironwood"s Linzess Lowers Abdominal Symptoms in IBS-C Patients

Ironwood (IRWD) and Allergan's Linzess meets the goal in a late-stage study for treating adult patients with IBS-C. Shares rise as the drug reduces bloating, pa.....»»

Category: smallbizSource: nytJun 19th, 2019

Ironwood, Allergan Investors React Positively After Duo"s Constipation Drug Found Effective

Shares of the small-cap, actively traded Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) were seeing positive momentum Wednesday on top of the 8.08% gain the stock recorded Tuesday. read more.....»»

Category: blogSource: benzingaJun 19th, 2019

Evolus drug delay a positive for Allergan, says Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 10th, 2019

U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents

The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native American tribe......»»

Category: topSource: reutersApr 15th, 2019

Stifel says abicipar improvement not enough to make Allergan drug competitive

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2019

Allergan kills talk of mega takeover bid for Shire

Drug-making giant Allergan says it has no plans to make a massive bid for biotech firm Shire, the latest twist in a saga that has played havoc with the companies' share prices......»»

Category: marketsSource: cnnApr 20th, 2018

Allergan Says It Won"t Make a Bid for Shire After All

Drug maker Allergan said it won’t submit an offer for rival Shire, changing its tune just hours after Allergan said it was considering such an offer......»»

Category: smallbizSource: wsjApr 19th, 2018

The next mega merger could be a $60 billion drug deal

Shares in drug company Shire surged in London as Japan's Takeda and Allergan consider bidding......»»

Category: topSource: cnnApr 19th, 2018

Rare Disease Drug Maker Shire’s Stock Spikes Amid Possible Bidding War Between Allergan and Takeda

Shire has already rebuffed a $62.5 billion offer from Japan's Takeda. In what would make for.....»»

Category: europeSource: fortuneApr 19th, 2018

Allergan"s stock surges after profit, revenue beat expectations

Shares of Allergan PLC surged 3.2% toward in premarket trade Monday, on track to swing to a year-to-date gain, after the drug maker reported first-quarter profit and sales that beat expectations. The com.....»»

Category: topSource: marketwatchApr 30th, 2018

Allergan CEO says Botox maker"s new depression drug could be an "absolute game-changer"

Jim Cramer sits down with Allergan Chairman and CEO Brent Saunders to hear about the pharmaceutical's latest ventures......»»

Category: topSource: madmoneyApr 30th, 2018

Walgreen, Kroger, Albertsons, HEB sue Allergan over dry-eye drug

By Jonathan Stempel.....»»

Category: topSource: moneycentralMay 16th, 2018

Brainstorm Health: Ebola Vaccine, Obamacare Profitability, New Migraine Drug, David Tepper and Allergan

Brainstorm Health Daily: May 18, 2018 Happy Friday. The World Health Organization has raised the threat level .....»»

Category: europeSource: fortuneMay 18th, 2018

This pot retailer has a $1.6B valuation and, coming soon, Canadian stock

They used to be drug dealers. Then they became dispensaries. Now we have cannabis retailers that "seek to replicate the Apple store model" and give customers "a comfortable, informative and nonthreatening environment.".....»»

Category: topSource: moneycentralMay 26th, 2018

Alder slips after Allergan releases data from migraine drug study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

Retailers experiment with blue lights to deter drug use

Colored bulbs cast an eerie blue glow in the restroom of a convenience store where people who inject heroin and other drugs have been seeking the relative privacy of the stalls to shoot up......»»

Category: topSource: washpostJun 24th, 2018

Retailers testing blue lights to ward off drug users

Retailers are experimenting with blue lights to discourage people from using drugs in store bathrooms by making it tougher for them to see their veins when injecting. .....»»

Category: topSource: usatodayJun 25th, 2018

Stores install blue lights in restrooms to deter drug use

Retailers are installing blue light bulbs in public .....»»

Category: topSource: usatodayJun 25th, 2018

Why Retailers Are Installing Blue Lights In Bathrooms to Discourage Drug Use

Convenience stores are experimenting with blue lights in bathrooms to deter drug use As the nation grapples with the harrowing effec.....»»

Category: europeSource: fortuneJun 25th, 2018

Amazon to buy PillPack in drug retailing push

(Reuters) - Amazon.com Inc said on Thursday it would buy online pharmacy PillPack, a small but significant step into the U.S. healthcare sector, sending shares of drug distributors and retailers lower......»»

Category: topSource: reutersJun 28th, 2018